These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22736296)

  • 1. Incorporating information regarding preimplantation genetic diagnosis into discussions concerning testing and risk management for BRCA1/2 mutations: a qualitative study of patient preferences.
    Hurley K; Rubin LR; Werner-Lin A; Sagi M; Kemel Y; Stern R; Phillips A; Cholst I; Kauff N; Offit K
    Cancer; 2012 Dec; 118(24):6270-7. PubMed ID: 22736296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.
    Derks-Smeets IA; Gietel-Habets JJ; Tibben A; Tjan-Heijnen VC; Meijer-Hoogeveen M; Geraedts JP; van Golde R; Gomez-Garcia E; van den Bogaart E; van Hooijdonk M; de Die-Smulders CE; van Osch LA
    Hum Reprod; 2014 May; 29(5):1103-12. PubMed ID: 24603131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis.
    Julian-Reynier C; Fabre R; Coupier I; Stoppa-Lyonnet D; Lasset C; Caron O; Mouret-Fourme E; Berthet P; Faivre L; Frenay M; Gesta P; Gladieff L; Bouhnik AD; Protière C; Noguès C
    Genet Med; 2012 May; 14(5):527-34. PubMed ID: 22241105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Awareness and attitude regarding reproductive options of persons carrying a BRCA mutation and their partners.
    Gietel-Habets JJ; de Die-Smulders CE; Derks-Smeets IA; Tibben A; Tjan-Heijnen VC; van Golde R; Gomez-Garcia E; Kets CM; van Osch LA
    Hum Reprod; 2017 Mar; 32(3):588-597. PubMed ID: 28073972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproductive decision-making in young female carriers of a BRCA mutation.
    Donnelly LS; Watson M; Moynihan C; Bancroft E; Evans DG; Eeles R; Lavery S; Ormondroyd E
    Hum Reprod; 2013 Apr; 28(4):1006-12. PubMed ID: 23293217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of Preimplantation Genetic Diagnosis in Female BRCA1 and BRCA2 Mutation Carriers.
    Mor P; Brennenstuhl S; Metcalfe KA
    J Genet Couns; 2018 Dec; 27(6):1386-1394. PubMed ID: 29858758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'The BRCA clock is ticking!': negotiating medical concerns and reproductive goals in preimplantation genetic diagnosis.
    Rubin LR; Werner-Lin A; Sagi M; Cholst I; Stern R; Lilienthal D; Hurley K
    Hum Fertil (Camb); 2014 Sep; 17(3):159-64. PubMed ID: 25105219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PGD for hereditary breast and ovarian cancer: the route to universal tests for BRCA1 and BRCA2 mutation carriers.
    Drüsedau M; Dreesen JC; Derks-Smeets I; Coonen E; van Golde R; van Echten-Arends J; Kastrop PM; Blok MJ; Gómez-García E; Geraedts JP; Smeets HJ; de Die-Smulders CE; Paulussen AD
    Eur J Hum Genet; 2013 Dec; 21(12):1361-8. PubMed ID: 23531862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer, BRCA mutations, and attitudes regarding pregnancy and preimplantation genetic diagnosis.
    Woodson AH; Muse KI; Lin H; Jackson M; Mattair DN; Schover L; Woodard T; McKenzie L; Theriault RL; Hortobágyi GN; Arun B; Peterson SK; Profato J; Litton JK
    Oncologist; 2014 Aug; 19(8):797-804. PubMed ID: 24951607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decisions and ethical issues among BRCA carriers and the use of preimplantation genetic diagnosis.
    Quinn GP; Vadaparampil ST; Bower B; Friedman S; Keefe DL
    Minerva Med; 2009 Oct; 100(5):371-83. PubMed ID: 19910890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary breast and ovarian cancer and reproduction: an observational study on the suitability of preimplantation genetic diagnosis for both asymptomatic carriers and breast cancer survivors.
    Derks-Smeets IA; de Die-Smulders CE; Mackens S; van Golde R; Paulussen AD; Dreesen J; Tournaye H; Verdyck P; Tjan-Heijnen VC; Meijer-Hoogeveen M; De Greve J; Geraedts J; De Rycke M; Bonduelle M; Verpoest WM
    Breast Cancer Res Treat; 2014 Jun; 145(3):673-81. PubMed ID: 24748567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An exploration of the communication preferences regarding genetic testing in individuals from families with identified breast/ovarian cancer mutations.
    Ratnayake P; Wakefield CE; Meiser B; Suthers G; Price MA; Duffy J; ; Tucker K
    Fam Cancer; 2011 Mar; 10(1):97-105. PubMed ID: 20878485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attitudes of high-risk women toward preimplantation genetic diagnosis.
    Quinn G; Vadaparampil S; Wilson C; King L; Choi J; Miree C; Friedman S
    Fertil Steril; 2009 Jun; 91(6):2361-8. PubMed ID: 18440521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What Black Women Know and Want to Know About Counseling and Testing for BRCA1/2.
    Adams I; Christopher J; Williams KP; Sheppard VB
    J Cancer Educ; 2015 Jun; 30(2):344-52. PubMed ID: 25301325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-related distress in unselected women with newly diagnosed breast or ovarian cancer undergoing BRCA1/2 testing without pretest genetic counseling.
    Høberg-Vetti H; Eide GE; Siglen E; Listøl W; Haavind MT; Hoogerbrugge N; Bjorvatn C
    Acta Oncol; 2019 Feb; 58(2):175-181. PubMed ID: 30334464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information.
    DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E
    Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort.
    Fortuny D; Balmaña J; Graña B; Torres A; Ramón y Cajal T; Darder E; Gadea N; Velasco A; López C; Sanz J; Alonso C; Brunet J
    Hum Reprod; 2009 Apr; 24(4):1000-6. PubMed ID: 19112076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Black and Minority Ethnic women's decision-making for risk reduction strategies after BRCA testing: Use of context and knowledge.
    Machirori M; Patch C; Metcalfe A
    Eur J Med Genet; 2019 May; 62(5):376-384. PubMed ID: 30550831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes to reproductive genetic testing in women who had a positive BRCA test before having children: a qualitative analysis.
    Ormondroyd E; Donnelly L; Moynihan C; Savona C; Bancroft E; Evans DG; Eeles R; Lavery S; Watson M
    Eur J Hum Genet; 2012 Jan; 20(1):4-10. PubMed ID: 21811309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproductive Endocrinologists' Utilization of Genetic Counselors for Oncofertility and Preimplantation Genetic Diagnosis (PGD) Treatment of BRCA1/2 Mutation Carriers.
    Goetsch AL; Wicklund C; Clayman ML; Woodruff TK
    J Genet Couns; 2016 Jun; 25(3):561-71. PubMed ID: 26567039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.